Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
June 6, 2013 -- The China Securities Regulatory Commission has terminated the IPO applications of fifteen China life science companies. To protect investors from inflated financial reports in companies that are going public, the CSRC is conducting a thorough review of all IPO filings. However, the agency has not disclosed any reasons for denying the IPO of any particular company. Each company had to file a self-evaluation, presumably answering pointed questions, with the CSRC by May 31. More details....
Help employers find you! Check out all the jobs and post your resume.
by Richard Daverman, PhD
June 6, 2013 -- The China Securities Regulatory Commission has terminated the IPO applications of fifteen China life science companies. To protect investors from inflated financial reports in companies that are going public, the CSRC is conducting a thorough review of all IPO filings. However, the agency has not disclosed any reasons for denying the IPO of any particular company. Each company had to file a self-evaluation, presumably answering pointed questions, with the CSRC by May 31. More details....
Help employers find you! Check out all the jobs and post your resume.
